Glypican 2 As A Cancer Marker And Therapeutic Target
US Application 62/350,976
Filed on 2016-06-16
Filed on 2016-06-16
HEXAMERIC TETRAHEDRAL RNA NANOSTRUCTURES
US Application 62/696,619
Filed on 2018-07-11
Filed on 2018-07-11
CATALYTICALLY HYPERACTIVE VARIANT OF HUMAN APOBEC3G PROTEIN
US Application 62/673,591
Filed on 2018-05-18
Filed on 2018-05-18
Human Monoclonal Antibodies Against Yeresinia Pestis
US Application 61/212,166
Filed on 2009-04-08
Filed on 2009-04-08
METHOD FOR TREATING OR PREVENTING PERIODONTITIS WITH GEOPROPOLIS EXTRACT
US Application 62/678,774
Filed on 2018-05-31
Filed on 2018-05-31
TETRAHEDRAL RNA SCAFFOLD FOR BIOLOGICAL APPLICATIONS
US Application 62/668,653
Filed on 2018-05-08
Filed on 2018-05-08
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
US Application 62/295,421
Filed on 2016-02-15
Filed on 2016-02-15
PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF
US Application 62/666,471
Filed on 2018-05-03
Filed on 2018-05-03
COMPOSITIONS AND METHODS FOR MODULATING ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION
US Application 62/661,234
Filed on 2018-04-23
Filed on 2018-04-23
CANCER TREATMENT METHODS
US Application 62/685,026
Filed on 2018-06-14
Filed on 2018-06-14